Tesamorelin, a lab-created peptide version of growth hormone-releasing hormone (GHRH) , is primarily applied in the treatment of visceral fat in individuals diagnosed with HIV. This compound click here works by encouraging the release of human growth hormone from the pituitary gland , which in turn can help in reducing abdominal storage. While not

Innovative retatrutide, a dual -action medication targeting simultaneously here GLP-1 and GIP receptors, is generating considerable interest within the medical community. Preliminary clinical research have revealed significant reductions in physical size and gains in physiological markers for individuals with excess weight . Scientists believe thi